These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17262712)

  • 1. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.
    McClelland RS; Sangare L; Hassan WM; Lavreys L; Mandaliya K; Kiarie J; Ndinya-Achola J; Jaoko W; Baeten JM
    J Infect Dis; 2007 Mar; 195(5):698-702. PubMed ID: 17262712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women.
    Van Der Pol B; Kwok C; Pierre-Louis B; Rinaldi A; Salata RA; Chen PL; van de Wijgert J; Mmiro F; Mugerwa R; Chipato T; Morrison CS
    J Infect Dis; 2008 Feb; 197(4):548-54. PubMed ID: 18275275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.
    Masese LN; Graham SM; Gitau R; Peshu N; Jaoko W; Ndinya-Achola JO; Mandaliya K; Richardson BA; Overbaugh J; McClelland RS
    BMC Infect Dis; 2011 Nov; 11():307. PubMed ID: 22047086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women.
    Mavedzenge SN; Pol BV; Cheng H; Montgomery ET; Blanchard K; de Bruyn G; Ramjee G; Straten Av
    Sex Transm Dis; 2010 Jul; 37(7):460-6. PubMed ID: 20562586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.
    McClelland RS; Richardson BA; Hassan WM; Chohan V; Lavreys L; Mandaliya K; Kiarie J; Jaoko W; Ndinya-Achola JO; Baeten JM; Kurth AE; Holmes KK
    J Infect Dis; 2008 May; 197(10):1361-8. PubMed ID: 18444793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroepidemiology of Trichomonas vaginalis in rural women in Zimbabwe and patterns of association with HIV infection.
    Mason PR; Fiori PL; Cappuccinelli P; Rappelli P; Gregson S
    Epidemiol Infect; 2005 Apr; 133(2):315-23. PubMed ID: 15816157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichomonas vaginalis and Human Immunodeficiency Virus Coinfection Among Women Under Community Supervision: A Call for Expanded T. vaginalis Screening.
    Davis A; Dasgupta A; Goddard-Eckrich D; El-Bassel N
    Sex Transm Dis; 2016 Oct; 43(10):617-22. PubMed ID: 27631355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study.
    McClelland RS; Lavreys L; Katingima C; Overbaugh J; Chohan V; Mandaliya K; Ndinya-Achola J; Baeten JM
    J Infect Dis; 2005 Feb; 191(3):333-8. PubMed ID: 15633091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of trichomoniasis in women in four African cities.
    Buvé A; Weiss HA; Laga M; Van Dyck E; Musonda R; Zekeng L; Kahindo M; Anagonou S; Morison L; Robinson NJ; Hayes RJ;
    AIDS; 2001 Aug; 15 Suppl 4():S89-96. PubMed ID: 11686470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women.
    Niccolai LM; Kopicko JJ; Kassie A; Petros H; Clark RA; Kissinger P
    Sex Transm Dis; 2000 May; 27(5):284-8. PubMed ID: 10821602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
    Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition.
    Martin HL; Richardson BA; Nyange PM; Lavreys L; Hillier SL; Chohan B; Mandaliya K; Ndinya-Achola JO; Bwayo J; Kreiss J
    J Infect Dis; 1999 Dec; 180(6):1863-8. PubMed ID: 10558942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Risk Factors of Trichomonas vaginalis Among Female Sexual Workers in Nairobi, Kenya.
    Lockhart A; Senkomago V; Ting J; Chitwa M; Kimani J; Gakure H; Kwatampora J; Patel S; Mugo N; Smith JS
    Sex Transm Dis; 2019 Jul; 46(7):458-464. PubMed ID: 31194717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, Treatment, Follow-up, and Persistence of Trichomonas vaginalis in Women 45 Years and Older According to HIV Status: A 10-Year Retrospective Cohort.
    Lazenby GB; Hill A; Tarleton J; Soper D
    Sex Transm Dis; 2020 May; 47(5):332-337. PubMed ID: 32149959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.
    Laga M; Manoka A; Kivuvu M; Malele B; Tuliza M; Nzila N; Goeman J; Behets F; Batter V; Alary M
    AIDS; 1993 Jan; 7(1):95-102. PubMed ID: 8442924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichomonas vaginalis infection: can we afford to do nothing?
    McClelland RS
    J Infect Dis; 2008 Feb; 197(4):487-9. PubMed ID: 18275270
    [No Abstract]   [Full Text] [Related]  

  • 17. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial.
    Kaul R; Kimani J; Nagelkerke NJ; Fonck K; Ngugi EN; Keli F; MacDonald KS; Maclean IW; Bwayo JJ; Temmerman M; Ronald AR; Moses S;
    JAMA; 2004 Jun; 291(21):2555-62. PubMed ID: 15173146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: implications for HIV prevention.
    Sorvillo F; Kovacs A; Kerndt P; Stek A; Muderspach L; Sanchez-Keeland L
    Am J Trop Med Hyg; 1998 Apr; 58(4):495-500. PubMed ID: 9574798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichomonas vaginalis and cervical cancer. A prospective study in China.
    Zhang ZF; Graham S; Yu SZ; Marshall J; Zielezny M; Chen YX; Sun M; Tang SL; Liao CS; Xu JL
    Ann Epidemiol; 1995 Jul; 5(4):325-32. PubMed ID: 8520717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.
    Baeten JM; Nyange PM; Richardson BA; Lavreys L; Chohan B; Martin HL; Mandaliya K; Ndinya-Achola JO; Bwayo JJ; Kreiss JK
    Am J Obstet Gynecol; 2001 Aug; 185(2):380-5. PubMed ID: 11518896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.